Verastem | VSTM - Pre Tax Profit


Verastem reported $-32.92M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Alaunos Therapeutics USD -7.84M 633K Dec/2023
AstraZeneca USD 3.91B 1.28B Mar/2026
Curis USD 19.36M 33.34M Dec/2025
Cytokinetics USD -206.03M 23M Mar/2026
Gilead Sciences USD 2.08B 1.56B Dec/2025
Incyte USD 343.6M 46.34M Mar/2026
Laboratory Of America USD 8.73B 8.54B Mar/2026
Novartis USD 3.84B 802M Mar/2026
Pfizer USD 5.18B 6.82B Mar/2026
Roche Holding CHF 4.79B 3.01B Jun/2025
TG Therapeutics USD 20.36M 24.73M Mar/2026
Verastem USD -32.92M 944K Dec/2025